| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 11 Feb 2025 | 3 Feb 2025 |
| Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve Unaudited financial Results for the quarter ended on 31-12-2024. Financial Results (As Per BSE Announcement Dated on: 11/02/2025) | ||
| Board Meeting | 21 Nov 2024 | 13 Nov 2024 |
| Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/11/2024 inter alia to consider and approve Declaration of Interim Dividend for the financial year 2024-25 Further the Company has fixed the Record Date of Tuesday 26th November 2024 for the purpose of payment of Interim Dividend on Equity Shares for the Financial Year 2024- 25 if declared by the Board. This is for your kind information and dissemination. The Board Meeting to be held on 16/11/2024 has been revised to 21/11/2024 The Board Meeting to be held on 16/11/2024 has been revised to 21/11/2024. 1) We hereby intimate the Stock Exchanges as per the provisions of Regulation 29 of the SEBI(LODR) Regulations, 2015, that a meeting of the Board of Directors of M/s. Indo Us Bio Tech Limited is scheduled on Thursday, 21st November, 2024, inter alia, to consider: (a) Declaration of Interim Dividend for the financial year 2024-25 2) Further, the Company has fixed the Record Date of Wednesday, 27th November, 2024 for the purpose of payment of Interim Dividend on Equity Shares for the Financial Year 2024- 25, if declared by the Board Further to our intimation dated 13th November, 2024 and in terms of Regulation 30 and Regulation 42 of the SEBI (LODR) Regulations, 2015 we wish to inform that, the Board of Directors of the Company at their meeting held today i.e. 21st November, 2024 has inter-alia; Declared an interim dividend of Rs. 0.25 per equity share of Rs. 10 each fully paid-up for the financial year 2024-25. As informed on 13th November, 2024, the Company has fixed Tuesday, 3rd December, 2024 as Record Date for the purpose of payment of Interim Dividend on equity shares for the Financial Year 2024-25 and the payment of Interim Dividend will be completed on or before 19th December, 2024. The meeting of the Board of Directors commenced at 11:20 AM to 11:40 AM. This is for your kind information and dissemination. (As Per BSE Announcement dated on 21.11.2024) | ||
| Board Meeting | 14 Nov 2024 | 6 Nov 2024 |
| Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve and take on record the Un-Audited Standalone Financial Result of the Company for the quarter and half year ended 30th September 2024 and to consider any other matter with the permission of the Board. Please take the same on your record. Thanking You Outcome of Board Meeting (As Per BSE Announcement Dated on 14.11.2024) | ||
| Board Meeting | 6 Sep 2024 | 6 Sep 2024 |
| Outcome of Board Meeting | ||
| Board Meeting | 8 Aug 2024 | 1 Aug 2024 |
| Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 ,inter alia, to consider and approve the Unaudited Standalone Financial Result of the Company for the quarter ended 30th June, 2024. Please take the same on your record. Thanking You, Pursuant to the Regulation 30 of the SEBI (Listing Obligation and Disclosures Requirements) Regulation, 2015, we wish to inform you that the Board of Directors of the Company at their meeting held on Thursday, 8th August 2024 at the registered office of the Company situated at 309, Shanti Mall, Satadhar Char Rasta, Opp. Navrang Tower, Sola Road, Ahmedabad, Gujarat, 380061 have considered and approved the following items of business: 1. The Board approved unaudited financial results of the company for the quarter ended 30th June, 2024 along with limited review reports obtained from the Auditor of the Company. The Board Meeting commenced at 11.00 A.M. and concluded at 11:40 A.M. You are requested to kindly take the same on record. Thanking you, Read less.. Financial Results for the quarter ended on 30th June, 2024. (As Per BSE Announcement Dated on 08.08.2024) | ||
| Board Meeting | 14 May 2024 | 17 May 2024 |
| We are submitting the Revised Financial Results; The statement of Standalone Audited Financial Results of the Company for the period of March 31, 2024. | ||
| Board Meeting | 2 May 2024 | 25 Apr 2024 |
| Quarterly Results & Audited Results With reference to above, we hereby inform that meeting of Board of Directors of the Company held today (i.e., 02/05/2024), in which Board has approved and adopted the standalone Audited Financial Results of the Company for the Quarter and year ended 31st March, 2024. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose the following: 1. Standalone Audited Financial Results of the Company for quarter and year ended on 31st March, 2024. 2. Auditors Report on Standalone Audited Financial Results. These are also being made available on the website of the Company at www.indousagriseeds.com Audited Financial Results for the year ended on 31st March, 2024. (As per BSE Announcement Dated on 02/05/2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
